Cargando…

Selecting the Best Combined Biological Therapy for Refractory Inflammatory Bowel Disease Patients

Current medical treatment for inflammatory bowel disease (IBD) does not achieve 100% response rates, and a subset of refractory and severely ill patients have persistent active disease after being treated with all possible drug alternatives. The combination of two biological therapies (CoT) seems a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mas, Eduard Brunet, Calvo, Xavier Calvet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877715/ https://www.ncbi.nlm.nih.gov/pubmed/35207347 http://dx.doi.org/10.3390/jcm11041076

Ejemplares similares

Pharmacologic therapy for inflammatory bowel disease refractory to steroids
por: Martínez-Montiel, MP, et al.
Publicado: (2015)

Designing biologic selectivity for inflammatory bowel disease – role of vedolizumab
por: Krupka, Niklas, et al.
Publicado: (2014)

Is there an optimal sequence of biologic therapies for inflammatory bowel disease?
por: Bressler, Brian
Publicado: (2023)

Breaking the Therapeutic Ceiling: Dual Biologic or Small Molecule Therapy for Refractory Inflammatory Bowel Disease
por: Ahmed, Waseem
Publicado: (2022)

Selective Forms of Therapy in the Treatment of Inflammatory Bowel Diseases
por: Kofla-Dłubacz, Anna, et al.
Publicado: (2022)

Optimizing the use of biological therapy in patients with inflammatory bowel disease
por: Moss, Alan C.
Publicado: (2015)

The Danish National Registry for Biological Therapy in Inflammatory Bowel Disease
por: Larsen, Lone, et al.
Publicado: (2016)

Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Effectiveness of Dual Biologic or Small Molecule Therapy for Achieving Endoscopic Remission in Refractory Inflammatory Bowel Disease
por: Abdullah, Israa, et al.
Publicado: (2022)

Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies
por: Kim, Duk Hwan, et al.
Publicado: (2017)

Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Combination therapy for inflammatory bowel disease
por: Sultan, Keith S, et al.
Publicado: (2017)

Incidence of Myelotoxicity and Other Adverse Effects Related to Thiopurine Starting in Patients with Inflammatory Bowel Disease: Retrospective Observational Study in a Third-Level Hospital
por: Grau, Gerard, et al.
Publicado: (2023)

Immunogenicity of biologics in inflammatory bowel disease
por: Vermeire, Séverine, et al.
Publicado: (2018)

Biologic targeting in the treatment of inflammatory bowel diseases
por: Bosani, Matteo, et al.
Publicado: (2009)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

Biological markers of disease activity in inflammatory bowel diseases
por: Szymanska, Edyta, et al.
Publicado: (2023)

Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics
por: Katsanos, Konstantinos H., et al.
Publicado: (2017)

Relationship between the Biological Clock and Inflammatory Bowel Disease
por: Giebfried, Jonathan, et al.
Publicado: (2023)

How to Choose the Biologic Therapy in a Bio-naïve Patient with Inflammatory Bowel Disease
por: Laredo, Viviana, et al.
Publicado: (2022)

Dual Biologic Therapy for the Treatment of Pediatric Inflammatory Bowel Disease: A Review of the Literature
por: Wlazło, Magdalena, et al.
Publicado: (2022)

Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies
por: Cheah, Eric, et al.
Publicado: (2023)

Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease
por: Fries, Walter, et al.
Publicado: (2023)

Best practices in DNA methylation: lessons from inflammatory bowel disease, psoriasis and ankylosing spondylitis
por: Whyte, Jessica M., et al.
Publicado: (2019)

Tofacitinib Adherence and Outcomes in Refractory Inflammatory Bowel Disease
por: Wiles, C Alex, et al.
Publicado: (2021)

Emerging Therapies for Inflammatory Bowel Disease
por: Weisshof, Roni, et al.
Publicado: (2018)

Iron Therapy in Inflammatory Bowel Disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Antioxidant Therapy in Inflammatory Bowel Diseases
por: Dziąbowska-Grabias, Katarzyna, et al.
Publicado: (2021)

Biologic Concentration Testing in Inflammatory Bowel Disease
por: Vaughn, Byron P., et al.
Publicado: (2015)

Advances in the development of new biologics in inflammatory bowel disease
por: Ungar, Bella, et al.
Publicado: (2016)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Opportunities and challenges for synthetic biology in the therapy of inflammatory bowel disease
por: Dong, Yumeng, et al.
Publicado: (2022)

Systematic review with meta‐analysis: the effects of immunomodulator or biological withdrawal from mono‐ or combination therapy in inflammatory bowel disease
por: Dohos, Dóra, et al.
Publicado: (2020)

Endoscopic Therapy in Inflammatory Bowel Diseases
por: Neumann, Helmut, et al.
Publicado: (2015)

Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease
por: Tran-Minh, My-Linh, et al.
Publicado: (2017)

New biologics and small molecules in inflammatory bowel disease: an update
por: Sabino, João, et al.
Publicado: (2019)

Role of hospitalization for inflammatory bowel disease in the post-biologic era
por: Soriano, Celine R, et al.
Publicado: (2021)

Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics
por: Deyhim, Tina, et al.
Publicado: (2023)

Diet supporting therapy for inflammatory bowel diseases
por: Kikut, Justyna, et al.
Publicado: (2021)

Electrical neuromodulation therapy for inflammatory bowel disease
por: Yasmin, Farah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_55ir5ds8ulv2jpbu5b5qbtt5v7